Eyes on Kestra: IBDs Are Still in High Demand
December 18, 2018 By Diana Britton, WealthManagement Stone Point may be looking to get out of the IBD business, but there’s still an appetite for such firms, even as the stock market suffers. Private equity firm Stone Point Capital is reportedly looking to offload Kestra Financial, the Austin-based independent broker/dealer it purchased less than three years ago. And while we may be headed for a bear market in stocks, it’s still a bull market for IBDs, industry observers say, especially for firms like Kestra. A couple years ago, there was a lot of noise around diminished demand for independent broker/dealers, especially as the Department of Labor’s fiduciary rule was set to take effect. Now that there’s less regulatory uncertainty, firms are focusing more on the future, with a bullish view. “Contrary to speculation a number...